(VIANEWS) – Shares of MAUNA KEA TECH (CAC 40: MKEA.PA) rose by a staggering 27.27% in 21 sessions from €0.55 to €0.70 at 15:01 EST on Monday, following the last session’s downward trend. CAC 40 is falling 0.29% to €7,297.76, following the last session’s upward trend.
MAUNA KEA TECH’s last close was €0.69, 30.61% under its 52-week high of €0.99.
About MAUNA KEA TECH
Mauna Kea Technologies SA develops and markets medical devices in Europe and internationally. The company offers range of medical devices, which includes gastroenterology, pulmonology, urology, and drug development. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, MAUNA KEA TECH has a trailing twelve months EPS of €-0.24.
More news about MAUNA KEA TECH (MKEA.PA).
